Arca
Skip to content
Tools
Tools

Behring Coagulation System

System, Multipurpose For In Vitro Coagulation Studies. 510(k) K970431, from Behring Diagnostics, Inc. (San Jose, CA). Product code JPA, class 2.

As of Nov 20, 2026, K970431 is an FDA 510(k) held by Behring Diagnostics, Inc., substantially equivalent on May 5, 1997 after 90 days, with 2 recalls tied to it in FDA's recall database.

  • Review time: 90 days
  • Recalls: 2
  • Cited as a predicate by: 2 devices

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

2 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K970431, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
Mar 2, 2021Z-1435-2021Siemens Healthcare Diagnostics Products GmbH has confirmed that the BCS XP System may be affected by a potential Emicizumab carryover on patient samples.Terminated
Jan 14, 2016Z-0825-2016False short clotting times for PT on BCS and BCS XP with Dade Innovin can occur. This has also an effect for false low PT INR values. These false short clotting times were observed only with turbid, hemolytic and/or…Terminated

Other JPA clearances

The newest 510(k)s for the same product code; their median review was 158 days; see every JPA device

Record

Type
Traditional
Received
Feb 4, 1997
Review panel
Hematology
Regulation
21 CFR 864.5425

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.